Literature DB >> 1677259

Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer.

N R Lemoine1, S Jain, F Silvestre, C Lopes, C M Hughes, E McLelland, W J Gullick, M I Filipe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1677259      PMCID： PMC1977330          DOI： 10.1038/bjc.1991.243

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  30 in total

1.  Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line.

Authors:  S Fukushige; K Matsubara; M Yoshida; M Sasaki; T Suzuki; K Semba; K Toyoshima; T Yamamoto
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

2.  Gene amplification in gastric and esophageal adenocarcinomas.

Authors:  J Houldsworth; C Cordon-Cardo; M Ladanyi; D P Kelsen; R S Chaganti
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

3.  Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.

Authors:  Y Yonemura; I Ninomiya; A Yamaguchi; S Fushida; H Kimura; S Ohoyama; I Miyazaki; Y Endou; M Tanaka; T Sasaki
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

4.  Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes.

Authors:  D W Cleveland; M A Lopata; R J MacDonald; N J Cowan; W J Rutter; M W Kirschner
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

5.  The c-erb B-2 proto-oncogene in human pancreatic cancer.

Authors:  P A Hall; C M Hughes; S L Staddon; P I Richman; W J Gullick; N R Lemoine
Journal:  J Pathol       Date:  1990-07       Impact factor: 7.996

6.  Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer.

Authors:  N R Lemoine; S Staddon; C Dickson; D M Barnes; W J Gullick
Journal:  Oncogene       Date:  1990-02       Impact factor: 9.867

7.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.

Authors:  A Ullrich; L Coussens; J S Hayflick; T J Dull; A Gray; A W Tam; J Lee; Y Yarden; T A Libermann; J Schlessinger
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

8.  Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.

Authors:  J Yokota; T Yamamoto; N Miyajima; K Toyoshima; N Nomura; H Sakamoto; T Yoshida; M Terada; T Sugimura
Journal:  Oncogene       Date:  1988-03       Impact factor: 9.867

9.  A monoclonal antibody to the human epidermal growth factor receptor.

Authors:  M D Waterfield; E L Mayes; P Stroobant; P L Bennet; S Young; P N Goodfellow; G S Banting; B Ozanne
Journal:  J Cell Biochem       Date:  1982       Impact factor: 4.429

10.  c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes.

Authors:  W J Gullick; S B Love; C Wright; D M Barnes; B Gusterson; A L Harris; D G Altman
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640
View more
  38 in total

1.  Poor survival after resection of early gastric cancer: extremes of survivorship analysis reveal distinct genomic profile.

Authors:  J Datta; E M Da Silva; C Kandoth; T Song; A E Russo; J M Hernandez; B S Taylor; Y Y Janjigian; L H Tang; D B Solit; V E Strong
Journal:  Br J Surg       Date:  2019-11-25       Impact factor: 6.939

Review 2.  Preoperative staging of gastric cancer as precondition for multimodal treatment.

Authors:  A Sendler; H J Dittler; H Feussner; H Nekarda; E Bollschweiler; U Fink; H Helmberger; H Höfler; J R Siewert
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

Review 3.  Vectors for cancer gene therapy.

Authors:  J Zhang; S J Russell
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 4.  Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network.

Authors:  Yu Sunakawa; Heinz-Josef Lenz
Journal:  Curr Treat Options Oncol       Date:  2015-04

5.  Are biopsy specimens predictive of HER2 status in gastric cancer patients?

Authors:  M Pirrelli; M L Caruso; M Di Maggio; R Armentano; A M Valentini
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

Review 6.  Roles of long noncoding RNAs in gastric cancer and their clinical applications.

Authors:  Weiliang Sun; Yunben Yang; Chunjing Xu; Yi Xie; Junming Guo
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-31       Impact factor: 4.553

7.  Prognostic significance of immunohistochemical expression of EGFR and C-erbB-2 oncoprotein in curatively resected gastric cancer.

Authors:  Hong Suk Song; Young Rok Do; In Ho Kim; Soo Sang Sohn; Kun Young Kwon
Journal:  Cancer Res Treat       Date:  2004-08-31       Impact factor: 4.679

8.  Expression of c-erbB-2 oncoprotein in gastric carcinoma: correlation with histopathologic characteristics and analysis of Ki-67.

Authors:  A Dursun; A Poyraz; B Celik; G Akyol
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 9.  HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice.

Authors:  Federica Grillo; Matteo Fassan; Francesca Sarocchi; Roberto Fiocca; Luca Mastracci
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

10.  Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.

Authors:  Chao He; Xue-Yi Bian; Xing-Zhi Ni; Dan-Ping Shen; Yan-Ying Shen; Hua Liu; Zhi-Yong Shen; Qiang Liu
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.